Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 157,600 | 133,600 | 58,500 | 22,400 | 142,200 |
| Depreciation Amortization | 204,500 | 152,100 | 100,100 | 48,000 | 186,200 |
| Income taxes - deferred | -11,800 | 6,300 | 2,500 | -1,500 | 52,400 |
| Accounts receivable | -12,900 | 74,100 | 38,700 | 71,800 | -4,900 |
| Accounts payable and accrued liabilities | 2,000 | -49,500 | 42,000 | -19,900 | -22,900 |
| Other Working Capital | -5,000 | -31,300 | 68,700 | 43,500 | -68,300 |
| Other Operating Activity | 12,500 | -29,700 | -53,900 | -53,400 | 61,900 |
| Operating Cash Flow | $346,900 | $255,600 | $256,600 | $110,900 | $346,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -104,800 | -63,400 | -44,500 | -20,400 | -86,100 |
| Net Acquisitions | -200,600 | -199,600 | -197,600 | -3,200 | -97,200 |
| Sale Of Investment | 46,800 | 46,800 | 5,900 | N/A | N/A |
| Other Investing Activity | 0 | -100 | -100 | -100 | -100 |
| Investing Cash Flow | $-258,600 | $-216,300 | $-236,300 | $-23,700 | $-183,400 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 476,300 | 237,500 | 255,700 | 240,900 | -20,600 |
| Debt Repayment | N/A | N/A | -11,800 | N/A | N/A |
| Common Stock Issued | 1,300 | 1,300 | 1,000 | 600 | 2,500 |
| Common Stock Repurchased | N/A | -4,400 | -3,300 | -3,300 | -1,800 |
| Dividend Paid | -132,200 | -99,500 | -66,800 | -34,000 | -287,300 |
| Other Financing Activity | -262,300 | -13,500 | -13,500 | -5,500 | 500 |
| Financing Cash Flow | $83,100 | $121,400 | $161,300 | $198,700 | $-306,700 |
| Beginning Cash Position | 109,500 | 109,500 | 109,500 | 109,500 | 253,000 |
| End Cash Position | 280,900 | 270,200 | 291,100 | 395,400 | 109,500 |
| Net Cash Flow | $171,400 | $160,700 | $181,600 | $285,900 | $-143,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 346,900 | 255,600 | 256,600 | 110,900 | 346,600 |
| Capital Expenditure | -112,100 | -70,100 | -48,600 | -23,900 | -89,200 |
| Free Cash Flow | 234,800 | 185,500 | 208,000 | 87,000 | 257,400 |